You need to be logged in to view this video
Venture-Stage Investing Made Easy and Impactful
Join Lou Basenese to learn why venture-stage investing in the public markets is the most transparent, liquid, potentially profitable, and impactful way to participate in venture capital. Find out how you can join an invite-only community of executives, entrepreneurs, innovators, and thought leaders dedicated to backing the technology leaders of the future. Finally, learn how special tax treatment under IRS Section 1202 can help you avoid paying taxes on up to 100% of capital gains up to $10 million or 10 times the original investment.
Lou Basenese is a well-known thought leader and advocate for young technology companies with promising intellectual property. He regularly shares his insights with national media outlets including FOX Business, Reuters, CNBC, and Yahoo! Finance. He brings decades of experience as a public venture investor and independent analyst, as well as a marketing, communications, investor, and public relations professional. As president and chief market strategist at MDB Capital, Mr. Basenese focuses on leveraging the firm’s unique and proven process to elevate new technology companies into market leaders and establish public ventures as a vital asset class to a much wider community of investors.
Prior to joining MDB Capital, Mr. Basenese served as founder and chief analyst for Disruptive Tech Research, an independent equity research and advisory firm focusing exclusively on disruptive technology companies. He also co-founded one of the web’s largest financial publishers with a daily circulation of more than 700,000 investors and served as an investment consultant for an institutional investment consulting practice with over $2 billion in assets at Morgan Stanley.
Mr. Basenese received a B.A. from the University of Florida and an MBA from the Crummer Graduate School of Business at Rollins College. He currently serves on the board of directors of Endra Life Sciences (NDRA) and The Roberto Clemente Health Clinic.
